Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong
· Delayed Price · Currency is HKD 3.430
+0.040 (1.18%)
At close: Mar 10, 2026
Zhaoke Ophthalmology Revenue
Zhaoke Ophthalmology had revenue of 15.80M CNY in the half year ending June 30, 2025, with 39.80% growth. This brings the company's revenue in the last twelve months to 35.36M, down -38.20% year-over-year. In the year 2024, Zhaoke Ophthalmology had annual revenue of 69.32M with 269.73% growth.
Revenue (ttm)
35.36M CNY
Revenue Growth
-38.20%
P/S Ratio
48.01
Revenue / Employee
130.96K CNY
Employees
270
Market Cap
1.86B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.43B |
| Cutia Therapeutics | 274.31M |
| Mabpharm | 464.53M |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 134.60M |
| Frontage Holdings | 1.99B |
| Kintor Pharmaceutical | 12.04M |
| Clover Biopharmaceuticals | 56.73M |
| Beijing Biostar Pharmaceuticals | 58.66M |